BioCair
BioCair is a privately-held life sciences logistics company providing temperature-controlled cold chain shipping, GDP-compliant transport, and specialized solutions for pharmaceutical, clinical trial, and cell and gene therapy customers across 170+ countries.
- Company typePrivate
- Founded1987
- HeadquartersCambridge, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What BioCair does
BioCair (legal entity Biocair International Limited) is a privately-held life sciences logistics company providing temperature-controlled cold chain and GDP-compliant shipping services to pharmaceutical companies, clinical trial sponsors and CROs, cell and gene therapy developers, and academic and commercial research institutions. Founded in 1986 and headquartered in Cambridge, UK, the company operates across more than 170 countries with wholly-owned subsidiaries in the United States (Delaware), Germany (Darmstadt), Singapore, and South Africa, employing between 251 and 500 staff.
The service offering is organized around four core expertise areas — life sciences logistics, cold chain logistics, global logistics, and regulatory compliance — and six specialized solutions covering cell and gene supply chains, clinical trial logistics, pharmaceutical supply chains, cryogenic transportation (liquid nitrogen dry vapor shippers), laboratory logistics, and dangerous goods transport. These are supported by Biocair Connect, a proprietary online shipment booking and tracking portal (track-and-trace, shipment history, real-time notifications, address book management), a customs brokerage subsidiary (Biocair Customs Brokerage LLC), and a packaging evaluation service. BioCair reports a 99.98% shipment integrity rate and retained its EcoVadis Silver Medal with an improved 2026 sustainability score.
Revenue is generated primarily through quotation-based transaction fees on freight forwarding and cold chain logistics services — packaging, import/export, collection, delivery, and transportation of temperature-sensitive consignments — with customary freight forwarder brokerages, commissions and disbursements embedded. Pricing is opaque (per-shipment quotation rather than published rate cards); standard payment terms are 30 days across UK, USA, Germany, South Africa, and Singapore, and 15 days in India. Go-to-market is sales-led: enterprise field sales supported by direct phone (US: +1 347 539 4980), inside sales in five languages, and a content-marketing program (Resources Hub, blog, case studies, industry events). The customer base is enterprise-tilted, with named logos including Sanofi-Genzyme, Polyplus Transfection, KAUST, Wellcome Sanger Institute, Valchiro, and WEP Clinical.
BioCair firmographics
Firmographics- Name
- BioCair
- Legal name
- Biocair International Limited
- Website
- http://www.biocair.com
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- BioCair is a privately-held life sciences logistics company providing temperature-controlled cold chain shipping, GDP-compliant transport, and specialized solutions for pharmaceutical, clinical trial, and cell and gene therapy customers across 170+ countries.
- Ownership category
- akta.pro rank
BioCair industry classification
Industry- Product category
- Pharmaceutical Cold Chain Logistics
- NAICS
- Transportation and Warehousing (48-49), Refrigerated Warehousing and Storage (493120), Nonscheduled Air Transportation (4812)
- SIC
- Trucking & Courier Services (No Air) (4210), Public Warehousing & Storage (4220)
- akta.pro primary industry
- Life Sciences Cold Chain Logistics (2–8°C, -20°C, -80°C) (HLAGAMAA)
- akta.pro secondary industries
- Cryogenic Logistics (LN2 Dry Shippers, -150°C) (HLAGAMAB), Pharma & Life Sciences Cold Chain Transport (GDP) (TLADAHAI), Dry Ice & Cryogenic (LN2) Handling and Transport Services (TLACAMAM), Biological Materials & Lab Specimen Cold Chain Logistics (Blood, Tissue, Samples) (TLAIAIAJ), Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK)
Keywords
Where BioCair is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
BioCair business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Freight forwarding and cold chain logistics services: BioCair charges fees for packaging, import/export, collection, delivery, and transportation of temperature-sensitive consignments. As a freight forwarder, it retains brokerages, commissions, allowances, and other customary freight forwarder remuneration. Services are priced via quotation (Biocair Quotation or Customer Order model), with fees and expenses/disbursements. The company offers customs brokerage services (Biocair Customs Brokerage LLC) as a complementary revenue stream. Customer payment terms are typically 30 days; 15 days for India.
- Specialized temperature-controlled transport solutions: Revenue is generated from specialized cryogenic transportation (liquid nitrogen dry vapor shippers), dangerous goods transport, and other bespoke logistics solutions. These are billed as part of the overall service contract or per-shipment quotation.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Custom quotation-based pricing for freight forwarding and cold chain logistics |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
BioCair product offering
Product offeringCore offering
BioCair is a life sciences logistics specialist providing temperature-controlled freight forwarding and cold chain supply chain solutions to pharmaceutical companies, clinical trial sponsors, cell and gene therapy developers, and research institutions. Services span ambient, refrigerated, frozen, and cryogenic (-196°C) transport across 170+ countries, with GDP-compliant operations, customs brokerage, dangerous goods handling, and dedicated project management for each shipment. The offering is enabled by Biocair Connect, a proprietary digital portal for booking, track-and-trace, and shipment notifications.
Product overview
BioCair is a life sciences logistics company providing pharmaceutical logistics and cold chain solutions. The offering consists of a comprehensive suite of logistics services organized around core expertise areas (life sciences logistics, cold chain logistics, global logistics, and regulatory compliance) and specialized solutions (cell and gene supply chain, clinical trial logistics, pharmaceutical supply chain, cryogenic transportation, laboratory logistics, and dangerous goods transport). These services are supported by a proprietary digital platform called Biocair Connect for shipment booking and tracking, complemented by customs brokerage and packaging technology services. The company has operated since 1986 and serves pharmaceutical professionals, researchers, and scientists across over 170 countries, achieving 99.98% shipments arriving in good condition.
Differentiator
Problem solved
Functional benefit
Brands
- Biocair Connect: Online shipment booking and tracking portal providing track and trace capabilities, shipment history review, shipment notifications, and address book management.
Products and services
- Life Sciences Logistics Safe, compliant, and timely delivery of temperature-sensitive biological materials and pharmaceutical shipments for researchers, scientists, and pharmaceutical professionals.
- Cold Chain Logistics Advanced temperature-controlled shipping solutions for time-sensitive pharmaceutical and biological materials requiring specific temperature ranges from ambient to cryogenic.
- Global Logistics Extensive global network of offices and experts operating in over 170 countries for international medical transportation needs.
- Regulatory Compliance GDP (Good Distribution Practice) compliant pharmaceutical supply chain solutions ensuring adherence to all local and international import/export regulations.
- Cell and Gene Supply Chain Dedicated expert support and enhanced global monitoring for cell and gene therapy logistics, featuring dedicated project management teams ensuring flawless chain of custody for personalized therapies.
- Clinical Trial Logistics Comprehensive clinical trial shipping solutions with multi-site collection and delivery capabilities for international trials.
- Pharmaceutical Supply Chain End-to-end pharmaceutical supply chain management from R&D and clinical trials through to manufacturing and distribution.
- Cryogenic Transportation Safe, compliant delivery of cryogenically frozen biological materials worldwide using innovative liquid nitrogen dry vapor shippers at temperatures down to -196°C.
- Laboratory Logistics Tailored logistics services for life sciences ensuring compliant, temperature-controlled transport of samples, reagents, and medical devices.
- Dangerous Goods Transport Safe transport of hazardous and radioactive goods in compliance with international regulations including IATA Dangerous Goods Regulations.
- Biocair Connect Proprietary shipment booking and tracking portal providing track and trace capabilities, shipment history review, shipment notifications, and address book management.
- Biocair Customs Brokerage Customs brokerage services to facilitate international shipments and ensure compliance with customs regulations across different jurisdictions.
- Packaging and Technology Evaluation, validation, and implementation of appropriate packaging solutions for temperature-sensitive shipments.
Quantifiable outcome
- 99.98% of shipments arriving in good condition
- +3 more outcomes
Companies that use BioCair
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles5 records
BioCair technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
BioCair partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights6 records
BioCair competitors and assessment
Company assessmentBroad incumbents
- FedEx Custom Critical: Provides time-sensitive, temperature-controlled freight services including life sciences and pharmaceutical shipments as part of FedEx's broader network. Competes with BioCair on critical healthcare shipments but is a broad logistics incumbent rather than a life sciences specialist.
- Kuehne+Nagel (Life Sciences & Healthcare): Runs a major global Life Sciences & Healthcare division with temperature-controlled airfreight, sea freight, and overland services including GxP-compliant solutions. A direct competitor in pharma cold chain freight forwarding but at much larger scale and broader portfolio.
- DHL Global Forwarding Life Sciences: Operates a dedicated life sciences and healthcare logistics arm providing GDP-compliant cold chain airfreight, road, and ocean services globally. Directly comparable as a pharma cold chain transport provider, but operates at vastly greater scale as part of Deutsche Post DHL Group.
Direct peers
- Cryoport Systems: Specializes in cryogenic logistics and temperature-controlled supply chain solutions for cell and gene therapies, reproductive medicine, and biologics. Highly comparable to BioCair's cryogenic transportation offering, with particular overlap in cell and gene therapy logistics.
- CSafe Global: Specializes in temperature-controlled container solutions and active/passive cold chain packaging for life sciences, with a strong presence in pharma airfreight. Comparable to BioCair as a specialist serving pharmaceutical cold chain needs, though more focused on container/packaging technology.
- Marken (UPS Healthcare): Clinical trial and cell/gene therapy logistics specialist now part of UPS Healthcare. Directly competes with BioCair in pharmaceutical and biologic shipment logistics, with particular strength in clinical supply chain and personalized therapy transport.
- World Courier: Specialist in pharmaceutical and clinical trial logistics with expertise in temperature-controlled and time-sensitive shipments, owned by Cencora (AmerisourceBergen). Closest direct peer to BioCair, offering very similar specialized services to pharma and biotech customers globally.
Emerging players
- Sonoco ThermoSafe: Provider of temperature-assured packaging and thermal solutions for pharma and life sciences shipments. Comparable as a player in life sciences cold chain, with overlap in temperature-controlled parcel shipments though more focused on packaging than forwarding.
- va-Q-tec: Provider of high-performance thermal insulation and temperature-controlled container solutions for pharma, biotech, and healthcare logistics. Comparable to BioCair in the life sciences cold chain value chain, but positioned as a packaging/insulation technology provider rather than a forwarder.
- Pelican BioThermal: Supplies reusable temperature-controlled shippers and parcel solutions for pharmaceutical, biologics, and life sciences logistics. Comparable to BioCair in serving the same life sciences cold chain customer base, though operating as a packaging specialist rather than a freight forwarder.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
BioCair social profiles
Digital presenceBioCair compliance and trust
Trust signalCompliance2 records
BioCair financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioCair leadership team
Management profileNumber of profiles
BioCair subsidiaries and ownership
Company hierarchySubsidiaries5 records
BioCair funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioCair M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioCair
What does BioCair do?
BioCair is a life sciences logistics specialist providing temperature-controlled freight forwarding and cold chain supply chain solutions to pharmaceutical companies, clinical trial sponsors, cell and gene therapy developers, and research institutions. Services span ambient, refrigerated, frozen, and cryogenic (-196°C) transport across 170+ countries, with GDP-compliant operations, customs brokerage, dangerous goods handling, and dedicated project management for each shipment. The offering is enabled by Biocair Connect, a proprietary digital portal for booking, track-and-trace, and shipment notifications.
Is BioCair a public or private company?
BioCair is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was BioCair founded?
BioCair was founded in 1987. It employs 251 to 500 people.
Where is BioCair based?
BioCair is headquartered in Cambridge, United States, in the North America region.
How does BioCair make money?
Two revenue lines are on record. Freight forwarding and cold chain logistics services are the primary driver. The others are specialized temperature-controlled transport solutions.
Who are BioCair's main competitors?
Broad incumbents on record are FedEx Custom Critical, Kuehne+Nagel (Life Sciences & Healthcare) and DHL Global Forwarding Life Sciences. Direct peers are Cryoport Systems, CSafe Global, Marken (UPS Healthcare) and World Courier. Emerging players are Sonoco ThermoSafe, va-Q-tec and Pelican BioThermal.
Does BioCair have an API?
No public API is recorded for BioCair.
What industry is BioCair in?
BioCair's product category is Pharmaceutical Cold Chain Logistics. Its primary akta.pro industry code is HLAGAMAA, Life Sciences Cold Chain Logistics (2–8°C, -20°C, -80°C), with a secondary code of HLAGAMAB, Cryogenic Logistics (LN2 Dry Shippers, -150°C). Its NAICS code is 48-49 and its SIC code is 4210.